Table 1 Clinical and laboratory data of thalassemic patients with normal glucose tolerance, impaired glucose tolerance and diabetes.
Parameters | Normal Glucose Tolerance(20) | Impaired Glucose Tolerance (10) | Diabetics (10) |
|---|---|---|---|
Male/Female | 14/6 | 5/5 | 6/4 |
|  | Mean ± SD | Mean ± SD | Mean ± SD |
Age (yrs) | 13.15 ± 3.56 | 14.80 ± 3.12 | 14.90 ± 2.69 |
Age of diagnosis (ms) | 8.5 ± 6.53 | 7.80 ± 3.22 | 6.70 ± 2.50 |
Duration of disease(yrs) | 12.42 ± 3.52 | 13.21 ± 3.3 | 14.34 ± 2.66 |
Duration of chelation (yrs) | 5.80 ± 3.07 | 5.55 ± 4.31 | 5.90 ± 2.96 |
Hb (g/dL) | 7.46 ± 1.24 | 7.53 ± 1.23 | 7.39 ± 0.86 |
AST (IU/L) | 64.80 ± 44.06 | 86.89 ± 40.07 | 74.80 ± 41.52 |
ALT (IU/L) | 66.40 ± 53.74 | 107.50 ± 84.53 | 67.70 ± 27.77 |
Serum ferritin (ng/ml) | 1999.90 ± 932.95 | 3223.60 ± 2188.23 | 3438 ± 1327.60 |
FBG (mg/dL) | 82.40 ± 7.16 | 107.8 ± 16.4 | 145.30 ± 29.50 |
PP (mg/dL) | 120.80 ± 9.55 | 175.2 ± 17.9 | 236.80 ± 29.81 |
Frequency of blood transfusion (wk interval) | 3.05 ± 0.6 | 3.2 ± 0.63 | 3.4 ± 0.84 |